Results 111 to 120 of about 35,246 (224)
Pyrene‐Conjugated, 2‐Pyridinecarboxaldehyde Derivatives as N‐Terminus‐Specific Tags for MALDI‐ and LALDI‐MS
Rapid Communications in Mass Spectrometry, Volume 40, Issue 8, 30 April 2026.ABSTRACT Background
Proteolytic processing is a fundamental post‐translational modification. Liquid chromatography–tandem mass spectrometry (LC–MS/MS) workflows are powerful for degradomic analyses but inherently sacrifice spatial information, a critical aspect for investigating biological systems such as aberrant extracellular matrix remodeling and ...Mujia Jenny Li, Murat Kucukdisli, Florian Braun, David W. Will, Nadine Meier, Bettina Wehrle, Larissa Chiara Meyer, Melanie Christine Föll, Oliver Schilling +8 morewiley +1 more sourceMechanical Behavior and Damage Evolution in Additively Manufactured Spinodoids
PAMM, Volume 26, Issue 1, March 2026.ABSTRACT
This research focuses on the mechanical behavior and damage evolution of additively manufactured spinodoid metamaterials under quasi‐static loading. Additive manufacturing (AM), especially laser powder bed fusion (LPBF), enables the fabrication of complex geometries from digital models and is particularly suited for architected materials like ...Vishal Sreenivasa, Michael Kaliskewiley +1 more sourcePrognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG‐MM5 Trial
European Journal of Haematology, Volume 116, Issue 3, Page 226-234, March 2026.ABSTRACT
Response assessment during treatment of multiple myeloma (MM) typically relies on immunofixation and serum electrophoresis. However, low levels of IgG and especially IgA paraprotein are difficult to quantify reliably. The Hevylite Assay quantifies the kappa and lambda fractions of IgG and IgA separately and is useful to determine response to ...Tim Richardson, Elias Mai, Ekaterina Menis, Axel Benner, Diana Tichy, Kaya Miah, Mathias Hänel, Britta Besemer, Amelie Boquoi, Igor Wolfgang Blau, Christian S. Michel, Hans Walter Lindemann, Snjezana Janjetovic, Peter Brossart, Helga Bernhard, Peter Reimer, Hans Salwender, Dirk Hose, Anja Seckinger, Marc Raab, Hartmut Goldschmidt, Christof Scheid, For the German‐Speaking Myeloma Multicenter Group (GMMG) HD5 Investigators, Koordinierungszentrum für Klinische Studien, KKS) Heidelberg, Facharztpraxis Hämatologie und Onkologie, Praxisnetzwerk Hämatologie/Internistische Onkologie, Facharztpraxis Onkologie, Caritas Krankenhaus Bad Mergentheim, MVZ Baden‐Baden, Charité Universitätsmedizin Berlin, Charité Universitätsmedizin Berlin, HELIOS Klinikum Berlin‐Buch, Medizinisches Versorgungszentrum, Facharztpraxis Onkologie, Onkologie Seestrasse, Klinikum Bielefeld Mitte, Facharztpraxis Onkologie, Universitätsklinikum Bonn, Johanniter Krankenhaus Bonn, Onkologie Rheinsieg, Städt. Klinikum Braunschweig, Onkologische Schwerpunktpraxis, Onkologische Praxis im Krankenhaus Buchholz, Onkologische Schwerpunktpraxis, Klinikum Chemnitz, Regiomed Kliniken GmbH, Carl‐Thiem‐Klinikum Cottbus, Klinikum Darmstadt, Onkologische Schwerpunktpraxis, Gemeinschaftspraxis für Hämatologie und Onkologie, Fachpraxis für Hämatologie und Onkologie, Universitätsklinikum Essen, Evangelisches Krankenhaus Essen‐Werden Zentrum für Innere Medizin, Universitätsklinikum Frankfurt, Agaplesion Medizinisches Versorgungszentrum, MVZ) Frankfurt, Krankenhaus Nordwest, Interdisziplinäres Facharztzentrum, IFS) Frankfurt, Vitanus GmbH, Frankfurter Rotkreuz‐Kliniken, PIOH‐Praxis für Internistische Onkologie und Hämatologie, Onkologische Facharztpraxis, Facharztpraxis für Hämatologie und Onkologie, Kath. Krankenhaus Hagen, Asklepios Klinik Altona, Asklepios Klinik St. Georg, Hämatologisch‐Onkologische Praxis Altona, Facharztpraxis für Hämatologie und Onkologie, OncoResearch Lerchenfeld UG, Evangelisches Krankenhaus Hamm gGmbH, Onkologische Schwerpunktpraxis, Klinikum Hanau GmbH, Klinikum Region Hannover, Onkologisches Ambulanzzentrum OAZ Hannover, Universitätsklinikum Heidelberg, Onkologische Schwerpunktpraxis, Onkologische Schwerpunktpraxis Heilbronn, SLK Kliniken Heilbronn GmbH, Facharztpraxis für Hämatologie und Tumorerkrankungen, Universitätsklinikum des Saarlandes, Klinikum Idar‐Oberstein, Schwerpunktpraxis für Hämatologie und Onkologie, Gemeinschaftspraxis für Hämatologie, Universitätsklinikum Köln, Onkologie Köln, Praxis Internistischer Onkologie und Hämatologie, Kliniken Köln, Facharztpraxis für Hämatologie, Onkologisches Zentrum Lebach, Klinikum der Stadt Ludwigshafen am Rhein, Onkologische Schwerpunktpraxis Lüneburg, Universitätsmedizin der Johannes Gutenberg‐Universität Mainz, MED Facharztzentrum, Universitätsmedizin Mannheim, Mannheimer Onkologie Praxis, Facharztpraxis für Innere Medizin, Praxis für Innere Medizin, AöR) Johannes Wesling Klinikum Minden, Kliniken Maria Hilf, Städtisches Klinikum München, Facharztpraxis für Innere Medizin, medius Kliniken, Onkologische Facharztpraxis, Paracelsus Kliniken, medius Kliniken, Medizinisches Versorgungszentrum am Siloah St. Trudbert‐Klinikum, Onkologische Praxis Pinneberg, Gemeinschaftspraxis Innere Medizin/Onkologie, Facharztpraxis für Onkologie, Diakonie‐Klinikum Schwäbisch Hall, Zaho‐Zentrum für ambulante Hämatologie und Onkologie, Diakonie Klinikum Jung‐Stilling, Gastroenterologie Onkologie Bodensee, Onkologische Schwerpunktpraxis Speyer, Marienhospital Stuttgart, Krankenhaus der Barmherzigen Brüder Trier, Klinikum Mutterhaus der Borromäerinnen Trier, Onkologische Schwerpunktpraxis am Brüderkrankenhaus Trier, Onkologie Rheinsieg, Universität Tübingen, OMM Optimed Mundial GmbH, Facharztpraxis für Onkologie, Ammerland Klinik, Facharztpraxis für Onkologie +125 morewiley +1 more sourceThe Caenorhabditis elegans DPF‐3 and human DPP4 have tripeptidyl peptidase activity
FEBS Letters, Volume 600, Issue 3, Page 324-333, February 2026.The dipeptidyl peptidase IV (DPPIV) family comprises serine proteases classically defined by their ability to remove dipeptides from the N‐termini of substrates, a feature that gave the family its name. Here, we report the discovery of a previously unrecognized tripeptidyl peptidase activity in DPPIV family members from two different species.Aditya Trivedi, Rajani Kanth Gudipatiwiley +1 more sourceBenchmarking Organic Photodiodes at the Noise Floor
Advanced Optical Materials, Volume 14, Issue 6, 9 February 2026.A precise measurement framework based on a calibrated, ultra‐low‐noise automated setup with open‐source Python scripts enables accurate benchmarking of photodiodes. The unique combination of time‐dependent current measurement under dark conditions, followed by continuous‐wave faint illumination, facilitates reliable extraction of photocurrent near ...Siddhartha Saggar, Giedrius Puidokas, Caroline Murawski +2 morewiley +1 more sourceA multiyear dataset detailing nekton abundance and biomass along living shorelines
Ecology, Volume 107, Issue 2, February 2026.Abstract
Living shorelines, a prevalent nature‐based coastal infrastructure technique, typically merge the restoration of coastal habitats (e.g., salt marsh, oyster reef) with gray infrastructure (e.g., rock or concrete breakwaters) to provide coastal erosion protection. With increasingly frequent and severe storms, living shorelines have been shown to Stephanie R. Valdez, Rachel K. Gittman, Megan E. Geesin, Brandon J. Puckett, Mariko A. Polk, Carolyn A. Currin, Carter S. Smith +6 morewiley +1 more sourceLocally Adaptive Non‐Hydrostatic Shallow Water Extension for Moving Bottom‐Generated Waves
International Journal for Numerical Methods in Fluids, Volume 98, Issue 2, Page 159-173, February 2026.This study proposes a locally adaptive non‐hydrostatic model, which is based on the non‐hydrostatic extension of the shallow water equations (SWE) with a quadratic pressure relation, and applies it to wave propagation generated by a moving bottom. To obtain the locally adaptive model, we investigate several potential adaptivity criteria based on the ...Kemal Firdaus, Jörn Behrenswiley +1 more sourceEffective Connectivity Reveals Dual‐Route Mechanism of Visual Prediction Precision via Insula and Pulvinar
Human Brain Mapping, Volume 47, Issue 2, February 1, 2026.Using 7‐Tesla fMRI and dynamic causal modelling (DCM), we identified a dual‐route mechanism for high‐precision predictions: direct excitatory modulation from the insula to V1, and indirect inhibitory modulation from the insula to V1 via the pulvinar.Linzhi Tao, Trevor Steward, Joshua Corbett, Rebecca K. Glarin, Tudor V. Sava, Marta I. Garrido +5 morewiley +1 more source